Search
forResearch 8 of 16
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Commonalities Between COVID-19 and Radiation Injury
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Current systemic treatment strategies for hidradenitis suppurativa
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Adverse Effects and Drug Interactions of Biologic Agents
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →